Takeda: Liver Diseases trials
The registry lists 10 Liver Diseases studies with Takeda as lead sponsor. 0 are open to participants now and 7 have results posted.
Phase 1 9Phase 3 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic FunctionCompletedNCT04056468Phase 1Results posted
- A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver ProblemsCompletedNCT03814005Phase 1Results posted
- A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954CompletedNCT03277274Phase 1Results posted
- Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic ImpairmentCompletedNCT02367872Phase 1Results posted
- Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic ImpairmentCompletedNCT02170220Phase 1Results posted
- Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver DysfunctionCompletedNCT01912222Phase 1Results posted
- Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver FunctionCompletedNCT01732263Phase 1Results posted
- A Study of TAK-279 in Adults With or Without Liver DamageCompletedNCT05976321Phase 1
- Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic ImpairmentCompletedNCT01134185Phase 1
- TachoSil Paediatric Liver Trial (TC-019-IN)CompletedNCT00365248Phase 3